A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Conditions
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Site 1001, Washington D.C., District of Columbia, United States
Site 1004, Louisville, Kentucky, United States
Site 1005, Houston, Texas, United States
Site 1002, Fairfax, Virginia, United States
Site 1201, Namur, Belgium
Site 1703, Meldola, Italy
Site 1702, Ravenna, Italy
Site 1802, Otwock, Poland
Site 1804, Poznan, Poland
Site 1801, Przemyśl, Poland
Site 1901, Craiova, Romania
Site 2013, Badajoz, Spain
Site 2014, Barcelona, Spain
Site 2003, Barcelona, Spain
Site 2002, Madrid, Spain
Site 2005, Madrid, Spain
Site 2004, Madrid, Spain
Site 2011, Madrid, Spain
Site 2010, Manresa, Spain
Site 2009, Valencia, Spain
Site 2015, Valencia, Spain
Site 2201, London, United Kingdom